Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Rogaine Extra Strength for Men recommended for approval as OTC

July 21, 1997

Selective RAR-gamma ligands described by Roche

July 21, 1997

Multicenter European clinical trials of REPEL initiated

July 18, 1997

Novel antiinflammatory agents prepared by French investigators

July 17, 1997

Regranex recommended for approval by FDA advisory committee

July 16, 1997

Allergan prepares compounds with retinoid-like activity

July 15, 1997

Interim U.S. phase III results reported for Gliatech's ADCON-L

July 15, 1997

Mechanism of topical absorption of antiandrogen drug investigated

July 15, 1997

New treatment reported for diaper dermatitis

July 15, 1997

Allergan reports agents with retinoid-like activity

July 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.